Metrics as of 10/14/2026, 12:22 PM (Berlin time), refresh in progress.
Abbott Laboratories Stock
Abbott Laboratories
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Robert Ford
- Employees
- 115,000
- Market cap
- $30.9 B
- IPO
- 30/12/2025
Abbott Laboratories is a healthcare company headquartered in Abbott Park, US, which engages in the discovery, development, manufacture, and sale of various healthcare products. The company operates through four primary segments. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Abbott Laboratories stock: price history
1D
-0.3%
1W
+3.7%
1M
-1.0%
6M
-0.1%
YTD
-19.8%
1Y
–
2Y
–
5Y
–
10Y
–
Ask the agents about Abbott Laboratories
Analyst assessment of Abbott Laboratories
0
STRONG BUY
1
BUY
0
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Buy
As of: 17/07/2015
Abbott Laboratories stock metrics
P/E
33.01
P/B
3.5
EV/EBITDA
18.11
RETURN ON EQUITY
-6.4%
NET MARGIN
9.1%
DEBT/EQUITY
-0.24
DIVIDEND YIELD
2.4%
AS OF
30/09/2020
Free float & liquidity
FREE FLOAT
–
FLOAT SHARES
–
AVG. DAILY VOLUME (30D)
31,587
Dividends
Comparable stocks
Frequently asked questions about Abbott Laboratories stock
What does Abbott Laboratories do?
Abbott Laboratories is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Robert Ford, the company employs around 115,000 people.
The IPO was on 30/12/2025; the stock trades on TSX under the ticker ABT.TO.
What do analysts say about Abbott Laboratories stock?
1 analysts rate the stock, the consensus is Buy (as of 17/07/2015).
This is an external assessment, not a statement by Market Jury.
Does Abbott Laboratories pay a dividend?
Yes. The last dividend was CA$0.11 per share, ex-date 15/10/2026, paid on 23/11/2026.
The dividend yield is 2.4% (as of 30/09/2020).
Which stocks are comparable to Abbott Laboratories?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Abbott Laboratories stock analyzed?
Clicking "Analyze stock" lets five strategies assess Abbott Laboratories against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.